Aspen Aerogels (NYSE: ASPN) reported Q1 EPS of ($0.24), $0.16 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $45.6 million versus the consensus estimate of $45.46 million.

GUIDANCE:

Aspen Aerogels sees FY2023 revenue of $200-250 million, versus the consensus of $234.6 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.